Medication adherence in schizophrenia: patient perspectives and the clinical utility of paliperidone ER.

Patient Preference and Adherence
Michael Birnbaum, Zafar Sharif

Abstract

Antipsychotic medications provide the foundation for treatment of acute exacerbations as well as relapse prevention in patients with schizophrenia as demonstrated by rigorous placebo-controlled trials. However, despite their proven effectiveness, poor adherence to prescribed antipsychotic regimens remains the most important driver of suboptimal clinical outcomes in this population. This paper reviews the magnitude of the problem of medication non-adherence in patients with schizophrenia and the various factors that contribute to non-adherence, with particular emphasis on factors related to antipsychotic medications. The profile of the latest atypical antipsychotic, paliperidone extended-release (ER) tablets, is then reviewed and the implications of its unique pharmacokinetic profile for adherence in this patient population are discussed.

References

Jan 1, 1991·Schizophrenia Bulletin·R J Wyatt
Jan 1, 1995·International Clinical Psychopharmacology·P E Bebbington
Jan 1, 1994·Schizophrenia Bulletin·P WeidenA Frances
Jan 5, 2002·The American Journal of Psychiatry·Christian R DolderDilip V Jeste
Apr 30, 2003·Psychiatric Services : a Journal of the American Psychiatric Association·Joseph MenzinJohn R Lloyd
Aug 16, 2003·Journal of Clinical Psychopharmacology·Christian R DolderDilip V Jeste
Aug 5, 2004·Psychiatric Services : a Journal of the American Psychiatric Association·Peter J WeidenJulie Locklear
Jan 27, 2005·The Journal of Clinical Psychiatry·Jose de LeonPeter J Wedlund
Sep 21, 2005·The New England Journal of Medicine·Jeffrey A LiebermanUNKNOWN Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators
Feb 8, 2006·European Psychiatry : the Journal of the Association of European Psychiatrists·M KamaliE O'Callaghan
May 3, 2006·The Journal of Clinical Psychiatry·Haya Ascher-SvanumJeff W Swanson
May 19, 2006·Schizophrenia Bulletin·Dawn I VelliganAlexander L Miller
Feb 8, 2007·CNS Drugs·Peter F BuckleyWilliam C Wirshing
Feb 9, 2007·Psychiatric Services : a Journal of the American Psychiatric Association·John D PietteMarcia Valenstein
May 31, 2007·Psychiatric Services : a Journal of the American Psychiatric Association·Matthew J ByerlyA John Rush

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy
sedation

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here